+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Takeda Pharmaceutical Company Limited - logo

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
Fabry Disease - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Fabry Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 217 Pages
  • Global
From
CCR5 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CCR5 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
GM-CSF Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

GM-CSF Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups

  • Report
  • November 2022
  • 54 Pages
  • Global
Fatty Liver Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Fatty Liver Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 102 Pages
  • Global
From
Non Alcoholic Fatty Liver Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 117 Pages
  • Global
From
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026 - Product Thumbnail Image

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026

  • Report
  • September 2026
  • 1500 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

  • Report
  • September 2022
  • 59 Pages
  • Italy
Antibody Drug Conjugates Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Antibody Drug Conjugates Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 210 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

  • Report
  • August 2022
  • 58 Pages
  • Asia Pacific
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
Lung Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Lung Cancer Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 373 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

  • Report
  • September 2022
  • 559 Pages
  • Spain
Cough Remedy - Global Strategic Business Report - Product Thumbnail Image

Cough Remedy - Global Strategic Business Report

  • Report
  • October 2026
  • 383 Pages
  • Global
From
Generic Pharmaceuticals Market Size, Share & Trends Analysis Report by Type, Application, Product, Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2026-2033 - Product Thumbnail Image

Generic Pharmaceuticals Market Size, Share & Trends Analysis Report by Type, Application, Product, Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2026-2033

  • Report
  • January 2026
  • 150 Pages
  • Global
From
Meropenem Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Meropenem Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 118 Pages
  • Global
From
Hypoparathyroidism - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Hypoparathyroidism - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 200 Pages
  • Global
From
Loading Indicator